The same trend was observed in thyroid cancer patients, as follows: FUCA1 RNA expression is high in papillary thyroid cancers (PTCs) which mostly carry wild-type p53, while low levels of FUCA1 RNA were detected in anaplastic thyroid cancers (ATCs) where p53 is frequently mutated. This evidence concerns the gene FUCA1 and thyroid gland papillary carcinoma.